Login to Your Account

Other News To Note

Friday, April 8, 2011
Vertex Pharmaceuticals Inc., of Cambridge, Mass., and Cystic Fibrosis Foundation Therapeutics Inc. (CFFT), a nonprofit drug discovery and development affiliate of the CF Foundation, will collaborate on the discovery and development of new medicines known as correctors that aim to treat the underlying cause of cystic fibrosis in people with the most common form of the disease.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription